Company: ABBV
Filing Date: 2025-02-14
Form Type: 10-K
Source: 0001551152-25-000020
Chunk: 331

Company: AbbVie Inc.
Filing Date: 2025-02-14
Form: 10-K
Item: Item 8
Chunk 331
---
-average remaining lease term and weighted-average discount rate for operating and finance leases:years ended December 31202420232022Weighted-average remaining lease term (years)Operating778Finance532Weighted-average discount rateOperating3.3 %3.0 %2.6 %Finance4.2 %3.6 %1.5 %The following table presents supplementary cash flow information regarding the company's leases:years ended December 31 (in millions)202420232022Cash paid for amounts included in the measurement of lease liabilitiesOperating cash flows from operating leases$204 $214 $212 Right-of-use assets obtained in exchange for new operating lease liabilities159 173 235 Finance lease cash flows were insignificant in 2024, 2023 and 2022. The following table summarizes the future maturities of AbbVie's operating and finance lease liabilities as of December 31, 2024:(in millions)OperatingleasesFinanceleasesTotal(a)2025$204 $18 $222 2026182 15 197 2027145 4 149 2028118 2 120 2029102 1 103 Thereafter223 2 225 Total lease payments974 42 1,016 Less: Interest99 2 101 Present value of lease liabilities$875 $40 $915 (a)Lease payments recognized as part of lease liabilities for optional renewal periods are insignificant.

2024 Form 10-K   |  74

Note 10 Debt, Credit Facilities and Commitments and Contingencies 

The following table summarizes long-term debt:as of December 31 (dollars in millions)2024 Effective interest rate (a)20242023 Effective interest rate (a)20231.25-3.85% aggregate notes due 20240.65-2.69% $— 0.65-2.69% $7,169 Floating rate term loans due 20256.22 %— 5.95 %2,000 3.60% senior notes due 20253.66 %3,750 3.66 %3,750 3.80% senior notes due 20252.09 %3,021 2.09 %3,021 2.95% senior notes due 20263.02 %4,000 3.02 %4